These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1054 related items for PubMed ID: 34913077

  • 1. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
    Zheng J, Liu C, Shi J, Wen K, Wang X.
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
    [Abstract] [Full Text] [Related]

  • 2. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J, Yang Y, Dong Y, Liu C.
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [Abstract] [Full Text] [Related]

  • 3. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
    Xu M, Wang J, Li H, Zhang Z, Cheng Z.
    Aging (Albany NY); 2020 Dec 03; 13(1):1017-1031. PubMed ID: 33291082
    [Abstract] [Full Text] [Related]

  • 4. CYP2E1 changes the biological function of gastric cancer cells via the PI3K/Akt/mTOR signaling pathway.
    Wang RY, Chen XW, Zhang WW, Jiang F, Liu MQ, Shen XB.
    Mol Med Rep; 2020 Feb 03; 21(2):842-850. PubMed ID: 31974627
    [Abstract] [Full Text] [Related]

  • 5. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y, Cheng H, Li W, Wu H, Yang Y.
    Int J Cancer; 2019 Aug 15; 145(4):1068-1082. PubMed ID: 30761524
    [Abstract] [Full Text] [Related]

  • 6. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H, Zhang L, Ding X, Sui X.
    Mol Med Rep; 2021 Jan 15; 23(1):. PubMed ID: 33179755
    [Abstract] [Full Text] [Related]

  • 7. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
    Xiao W, Liu Y, Dai M, Li Y, Peng R, Yu S, Liu H.
    Int J Mol Med; 2020 Aug 15; 46(2):700-708. PubMed ID: 32626924
    [Abstract] [Full Text] [Related]

  • 8. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z.
    Tissue Cell; 2022 Aug 15; 77():101817. PubMed ID: 35679685
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway.
    Xu F, Zhu F, Wang W, Gao W, Chen X, Yu C.
    Cell Mol Biol (Noisy-le-grand); 2020 Jun 05; 66(3):159-164. PubMed ID: 32538764
    [Abstract] [Full Text] [Related]

  • 10. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.
    Wei Z, Xia K, Zheng D, Gong C, Guo W.
    Mol Med; 2023 Oct 03; 29(1):133. PubMed ID: 37789274
    [Abstract] [Full Text] [Related]

  • 11. STEAP2 promotes osteosarcoma progression by inducing epithelial-mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2.
    Zhang D, Liu H, Wang W, Xu G, Yin C, Wang S.
    Cancer Biol Ther; 2022 Dec 31; 23(1):1-16. PubMed ID: 36316642
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB, Wang JA, Lv RQ.
    Eur Rev Med Pharmacol Sci; 2019 Feb 31; 23(4):1418-1427. PubMed ID: 30840262
    [Abstract] [Full Text] [Related]

  • 13. TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation.
    Ma K, Zhang C, Li W.
    Cell Cycle; 2020 Sep 31; 19(18):2327-2339. PubMed ID: 32804027
    [Abstract] [Full Text] [Related]

  • 14. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
    Zhu G, Liu X, Li H, Yan Y, Hong X, Lin Z.
    Int J Immunopathol Pharmacol; 2018 Sep 31; 32():2058738418814341. PubMed ID: 30477356
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY, Zhao ZQ, Bai R, Zhao W, Wang YX, Xue HQ, Sun L, Sun C, Feng W, Guo SB.
    Oncol Rep; 2020 Apr 31; 43(4):1169-1186. PubMed ID: 32323781
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T, Chen H, Wang P, Yang N, Bao J.
    Cancer Biother Radiopharm; 2020 Nov 31; 35(9):661-672. PubMed ID: 32275162
    [Abstract] [Full Text] [Related]

  • 17. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
    Jin R, Jin YY, Tang YL, Yang HJ, Zhou XQ, Lei Z.
    Oncol Rep; 2018 Jun 31; 39(6):3034-3040. PubMed ID: 29620278
    [Abstract] [Full Text] [Related]

  • 18. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
    Zhou Y, Zhu LB, Peng AF, Wang TF, Long XH, Gao S, Zhou RP, Liu ZL.
    Mol Med Rep; 2015 Feb 31; 11(2):1352-7. PubMed ID: 25351625
    [Abstract] [Full Text] [Related]

  • 19. [Kuwanon G inhibits growth, migration and invasion of gastric cancer cells by regulating the PI3K/AKT/mTOR pathway].
    Geng Z, Yang J, Niu M, Liu X, Shi J, Liu Y, Yao X, Zhang Y, Zhang X, Hu J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Aug 20; 44(8):1476-1484. PubMed ID: 39276043
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F, Zhou P, Wang Z, Zhang XL, Liao FX, Hu Y, Chang J.
    Arch Biochem Biophys; 2020 Jun 15; 686():108351. PubMed ID: 32240636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.